title: Analyses of p53 antibodies in sera of patients with lung carcinoma define immunodominant regions in the p53 protein.
abstract: Antibodies specific for human p53 were analysed in sera of lung cancer patients. We detected p53 antibodies in the sera of 24% (10/42) of patients with lung carcinoma. The distribution was as follows: 4/9 small-cell lung carcinomas (SCLCs), 2/18 squamous cell lung carcinomas (SCCs), 2/10 adenocarcinomas (ADCs) and 2/5 large-cell lung carcinomas (LCCs). p53 antibodies were always present at the time of diagnosis and did not appear during progression of the disease. Using an original peptide-mapping procedure, we precisely localised the p53 epitopes recognised by p53 antibodies. Immunodominant epitopes reacting with antibodies were localised in the amino and carboxy termini of the protein, similar to those found in breast carcinoma patients or in animals immunised with p53. In light of these data, we suggest that p53 antibodies occur via a self-immunisation process that is the consequence of p53 accumulation in tumour cells. p53 antibodies were also detected in two patients without detected malignant disease. One of these patients died 6 months later of lung carcinoma, suggesting that p53 antibodies may be a precocious marker of p53 alteration.
authors.affiliation: Unité 301 INSERM, Institut de Génétique Moléculaire, Paris, France.
authors.forename: B
authors.initials: B
authors.lastname: Schlichtholz
authors.forename: J
authors.initials: J
authors.lastname: Trédaniel
authors.forename: R
authors.initials: R
authors.lastname: Lubin
authors.forename: G
authors.initials: G
authors.lastname: Zalcman
authors.forename: A
authors.initials: A
authors.lastname: Hirsch
authors.forename: T
authors.initials: T
authors.lastname: Soussi
mesh_terms: D000230:Adenocarcinoma / Q000097:blood* / Q000276:immunology; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000906:Antibodies / Q000097:blood*; D018287:Carcinoma, Large Cell / Q000097:blood* / Q000276:immunology; D018288:Carcinoma, Small Cell / Q000097:blood* / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000097:blood* / Q000276:immunology; D004417:Dyspnea / Q000097:blood / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D000939:Epitopes / Q000276:immunology*; D005260:Female; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000097:blood / Q000276:immunology; D008175:Lung Neoplasms / Q000097:blood* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D016159:Tumor Suppressor Protein p53 / Q000276:immunology*
chemical_list: D000906:Antibodies; D000939:Epitopes; D016159:Tumor Suppressor Protein p53